Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 48

Sort by

Sort Order Select

Journal Articles

Characterizing the Mechanism of NE and P3 Cross-Presentation in B Cell-Acute Lymphoblastic Leukemia

Selena Carmona, MS, Celine Kerros, PhD, Alexander Perakis, Anne Philip, Pariya Sukhumalchandra, Anna Sergeeva, PhD, Lisa St. John, Mao Zhang, MPH, Na Qiao, Elizabeth Mittendorf, Gheath Alatrash, DO, PhD, Jeffrey J. Molldrem, MD

Blood (2017) 130 (Supplement 1): 3596.

https://doi.org/10.1182/blood.V130.Suppl_1.3596.3596

Published: 2017

Journal Articles

Neutrophil-Secreted Proteinase 3 Mediates Metastasis of Prostate Cancer Cells Expressing RAGE to the Bone Marrow

Mikhail Kolonin, PhD, Anna Sergeeva, PhD, Daniela Staquicini, PhD, Jeffrey J. Molldrem, MD, Renata Pasqualini, PhD, Wadih Arap, MD PhD

Blood (2016) 128 (22): 1025.

https://doi.org/10.1182/blood.V128.22.1025.1025

Published: 2016

Journal Articles

Graded PU.1 Levels Regulate Granulocyte Vs. Macrophage Genes Via Multiple Enhancer Elements

Vitek Pospisil, PhD, Pavle Krsmanovic, PhD, Jan Valecka, MSc, Kamila Chramostová, Vojtech Kulvait, MSc, Jiri Zavadil, PhD, Martin Vokurka, MD PhD, Peter Laslo, PhD, Tomas Stopka, MD PhD

Blood (2016) 128 (22): 403.

https://doi.org/10.1182/blood.V128.22.403.403

Published: 2016

Journal Articles

Proteinase 3 Is Expressed in Stem Cells and Regulates Bone Marrow Hematopoiesis

Kutay Karatepe, MS, Hongbo R. Luo, PhD

Blood (2015) 126 (23): 1159.

https://doi.org/10.1182/blood.V126.23.1159.1159

Published: 2015

Journal Articles

Inhibition of T Cell Proliferation By Granulocyte Membrane-Associated Proteinase 3 Is Reversed By Blocking the Interaction of Calreticulin with LRP on T Cells

Tian-Hui Yang, PhD, Lisa S. St. John, PhD, Karen Clise-Dwyer, PhD, Kathryn Ruisaard, MS, Gheath Alatrash, DO, PhD, Jeffrey J. Molldrem, MD

Blood (2014) 124 (21): 4110.

https://doi.org/10.1182/blood.V124.21.4110.4110

Published: 2014

Journal Articles

Membrane-Associated Proteinase 3 On Granulocytes and Myeloid Leukemia Mediates Reversible Inhibition of T Cell Proliferation Associated with Altered ZAP70 and ERK Signaling

Tian-Hui Yang, MD, PhD, Karen Clise-Dwyer, PhD, S Lisa, St. John, PhD, Gheath Alatrash, DO, PhD, Kathryn Ruisaard, MS, Sijie Lu, PhD, Jeffrey J. Molldrem, MD

Blood (2012) 120 (21): 1031.

https://doi.org/10.1182/blood.V120.21.1031.1031

Published: 2012

Journal Articles

Multiple Myeloma Cross-Presents Neutrophil Elastase and Proteinase 3 and Becomes Susceptible to PR1-Targeting Immunotherapy

Gheath Alatrash, DO, PhD, Pariya Sukhumalchandra, BS, Mao Zhang, MPH, Anna Sergeeva, PhD, Haroon Jakher, BS, Jinsheng Weng, Ph.D, Lisa S St. John, PhD, Kathryn Ruisaard, BS, Karen Clise-Dwyer, PhD, Sijie Lu, PhD, Jeffrey J. Molldrem, MD

Blood (2012) 120 (21): 4973.

https://doi.org/10.1182/blood.V120.21.4973.4973

Published: 2012

Journal Articles

Membrane-Associated Proteinase 3 on Granulocytes and Myeloid Leukemia Mediates Reversible Inhibition of T Cell Proliferation

Tian-Hui Yang, MD, PhD, Karen Clise-Dwyer, PhD, Gheath Alatrash, DO, PhD, Kathryn Ruisaard, MS, Shoudan Liang, PhD, Jeffrey J. Molldrem, MD

Blood (2011) 118 (21): 1916.

https://doi.org/10.1182/blood.V118.21.1916.1916

Published: 2011

Journal Articles

Protein Profiling of Two Mouse BCR-ABL-Transformed Cell Lines

Monika Krmencikova, Martina Petrackova, Vladimir Vonka, MD, PhD

Blood (2011) 118 (21): 4720.

https://doi.org/10.1182/blood.V118.21.4720.4720

Published: 2011

Journal Articles

Generation of Multi-Antigen Specific T Cells for Adoptive Immunotherapy of Myeloid Leukemia and Identification of MHC Class I and II-Restricted Peptides for WT1, Proteinase 3 and Human Neutrophil Elastase

Gerrit Weber, MD, Ulrike Gerdemann, MD, Nancy F. Hensel, BS, Ann M. Leen, PhD, Catherine M. Bollard, MD, A. John Barrett, MD

Blood (2011) 118 (21): 2985.

https://doi.org/10.1182/blood.V118.21.2985.2985

Published: 2011

Journal Articles

Soluble Inflammatory Mediators Proteinase-3 and Neutrophil Elastase Are Targeted by PR1-Specific Immunotherapy After Cellular Uptake and Cross Presentation of PR1 Peptide by Breast Cancer Cells

Gheath Alatrash, DO, PhD, Elizabeth Mittendorf, MD, Anna Sergeeva, PhD, Pariya Sukhumalchandra, BS, Na Qiao, PhD, Kathryn Quintanilla, MS, Mao Zhang, MPH, Lu Sijie, PhD, Karen Clise-Dwyer, PhD, Jeffrey J. Molldrem, MD

Blood (2010) 116 (21): 2089.

https://doi.org/10.1182/blood.V116.21.2089.2089

Published: 2010

Journal Articles

Proteinase 3 Mediates Enzyme-Independent Reversible Inhibition of CD4 and CD8 T Cell Proliferation by Blocking G 1 -S Transition

Tian-Hui Yang, MD., PhD, Gheath Alatrash, DO, PhD, Karen Clise-Dwyer, PhD, Kathryn Quintanilla, MS, Sijie Lu, PhD, Jeffrey J. Molldrem, MD

Blood (2010) 116 (21): 2099.

https://doi.org/10.1182/blood.V116.21.2099.2099

Published: 2010

Journal Articles

Neutrophil Proteinase 3 (PR3) Enhances Vascular Endothelial Cell Barrier Function

Christopher Kuckleburg, PhD, Peter J. Newman, PhD

Blood (2010) 116 (21): 2108.

https://doi.org/10.1182/blood.V116.21.2108.2108

Published: 2010

Journal Articles

Interferon Alpha 2a (IFN) Maintenance Therapy After Imatinib Plus IFN Induction Therapy in Chronic Myeloid Leukemia (CML) Induces Stable Long-Term Molecular Remissions and Is Associated with Increased Proteinase 3 (PR3) Expression and the Presence of PR1-Specific T-Cells.

Andreas Burchert, MD, Martin C Müller, MD, Philippe Kostrewa, med., Philipp Erben, MD, Tilman Bostel, MD, Simone Liebler, MD, Rüdiger Hehlmann, MD, Andreas Neubauer, MD, Andreas Hochhaus, MD

Blood (2009) 114 (22): 647.

https://doi.org/10.1182/blood.V114.22.647.647

Published: 2009

Journal Articles

TCR and DNAM Dependent Lysis of Acute Monocytic Leukemia (AMoL) by Vg9Vd2 T Lymphocytes.

Julie Gertner-Dardenne, Eloise Perrot, Thomas Prebet, MD, Aude Charbonnier, Helene Sicard, PhD, Norbert Vey, Daniel Olive, MD, PhD

Blood (2009) 114 (22): 1041.

https://doi.org/10.1182/blood.V114.22.1041.1041

Published: 2009

Journal Articles

Proteinase-3 Deficiency Contributes to Thrombotic Risk in PNH

Anna M. Jankowska, MSc, Hadrian Szpurka, MSc, PhD, Andrew E. Schade, MD, PhD, Sanjay R. Mohan, MD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2008) 112 (11): 406.

https://doi.org/10.1182/blood.V112.11.406.406

Published: 2008

Journal Articles

Identification of Proteinase 3 (PR3) Gene Overexpresison and Protein Delocalization in Core Binding Factor Leukemias as a Mechanism Leading to Increased Chemosensitivity.

Daniela Cilloni, MD, PhD, Ilaria Defilippi, PhD, Sonia Carturan, PhD, Chiara Maffè, PhD, Marisa Pautasso, MD, Ilaria Iacobucci, Giovanni Martinelli, MD, Emanuela Messa, MD, Antonia Rotolo, Enrico Bracco, PhD, Giuseppe Saglio, MD

Blood (2008) 112 (11): 204.

https://doi.org/10.1182/blood.V112.11.204.204

Published: 2008

Journal Articles

Genetic and Proteomic Analysis of Functionally Distinct Human Hematopoietic Stem Cells from Bone Marrow, Mobilized Peripheral Blood, and Cord Blood

Brahmananda Reddy Chitteti, Ph.D., Bradley Poteat, Mu Wang, Ph.D., Yunlong Liu, Ph.D., Edward F. Srour, PhD

Blood (2008) 112 (11): 1324.

https://doi.org/10.1182/blood.V112.11.1324.1324

Published: 2008

Journal Articles

Leukemia-Associated Primary Granule Proteins (PGPs) Elastase-2 and Proteinase-3 Are Aberrantly Expressed in Solid Tumors: A Potential Therapeutic Target for PR1-Directed Immunotherapy

Gheath Alatrash, Luis M Vence, Wendy Woodward, Naoto T Ueno, Jeffrey J Molldrem

Blood (2008) 112 (11): 5440.

https://doi.org/10.1182/blood.V112.11.5440.5440

Published: 2008

Journal Articles

Proteinase 3 Mediates Direct Inhibition of CD4 and CD8 T Lymphocyte Proliferation by Inducing Enzyme-Independent G0/G1 Cell Cycle Arrest

Tian-Hui Yang, MD., PhD, Kathryn E Quintanilla, Amy M Cortez, Jeffrey J. Molldrem, MD

Blood (2008) 112 (11): 4916.

https://doi.org/10.1182/blood.V112.11.4916.4916

Published: 2008

NARROW

Characterizing the Mechanism of NE and P3 Cross-Presentation in B Cell-Acute Lymphoblastic Leukemia

Neutrophil-Secreted Proteinase 3 Mediates Metastasis of Prostate Cancer Cells Expressing RAGE to the Bone Marrow

Graded PU.1 Levels Regulate Granulocyte Vs. Macrophage Genes Via Multiple Enhancer Elements

Proteinase 3 Is Expressed in Stem Cells and Regulates Bone Marrow Hematopoiesis

Inhibition of T Cell Proliferation By Granulocyte Membrane-Associated Proteinase 3 Is Reversed By Blocking the Interaction of Calreticulin with LRP on T Cells

Membrane-Associated Proteinase 3 On Granulocytes and Myeloid Leukemia Mediates Reversible Inhibition of T Cell Proliferation Associated with Altered ZAP70 and ERK Signaling

Multiple Myeloma Cross-Presents Neutrophil Elastase and Proteinase 3 and Becomes Susceptible to PR1-Targeting Immunotherapy

Membrane-Associated Proteinase 3 on Granulocytes and Myeloid Leukemia Mediates Reversible Inhibition of T Cell Proliferation

Protein Profiling of Two Mouse BCR-ABL-Transformed Cell Lines

Generation of Multi-Antigen Specific T Cells for Adoptive Immunotherapy of Myeloid Leukemia and Identification of MHC Class I and II-Restricted Peptides for WT1, Proteinase 3 and Human Neutrophil Elastase

Soluble Inflammatory Mediators Proteinase-3 and Neutrophil Elastase Are Targeted by PR1-Specific Immunotherapy After Cellular Uptake and Cross Presentation of PR1 Peptide by Breast Cancer Cells

Proteinase 3 Mediates Enzyme-Independent Reversible Inhibition of CD4 and CD8 T Cell Proliferation by Blocking G 1 -S Transition

Neutrophil Proteinase 3 (PR3) Enhances Vascular Endothelial Cell Barrier Function

Interferon Alpha 2a (IFN) Maintenance Therapy After Imatinib Plus IFN Induction Therapy in Chronic Myeloid Leukemia (CML) Induces Stable Long-Term Molecular Remissions and Is Associated with Increased Proteinase 3 (PR3) Expression and the Presence of PR1-Specific T-Cells.

TCR and DNAM Dependent Lysis of Acute Monocytic Leukemia (AMoL) by Vg9Vd2 T Lymphocytes.

Proteinase-3 Deficiency Contributes to Thrombotic Risk in PNH

Identification of Proteinase 3 (PR3) Gene Overexpresison and Protein Delocalization in Core Binding Factor Leukemias as a Mechanism Leading to Increased Chemosensitivity.

Genetic and Proteomic Analysis of Functionally Distinct Human Hematopoietic Stem Cells from Bone Marrow, Mobilized Peripheral Blood, and Cord Blood

Leukemia-Associated Primary Granule Proteins (PGPs) Elastase-2 and Proteinase-3 Are Aberrantly Expressed in Solid Tumors: A Potential Therapeutic Target for PR1-Directed Immunotherapy

Proteinase 3 Mediates Direct Inhibition of CD4 and CD8 T Lymphocyte Proliferation by Inducing Enzyme-Independent G0/G1 Cell Cycle Arrest

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only